Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

A guide to using complementary alternative medicines in cancer

Article Abstract:

The potential risks associated with the complementary alternative medicines (CAMs) taken by the cancer patients are described. The pharmacological, physical and psychological approaches demonstrating the significant effectiveness on side effects of the drugs are discussed.

Author: Werneke, Ursula
Publisher: Macmillan Publishing Ltd.
Publication Name: Nursing Times
Subject: Health
ISSN: 0954-7762
Year: 2005
Risk factors, Drug therapy, Cancer, Alternative medicine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Is personality disorder treatable?

Article Abstract:

Personality disorder is treatable and can be diagnosized by getting to know the nature and behavior of the person and by listening to their experiences. Some methods of coping with people with personality disorder are presented.

Author: Rayner, Gillian, Wilkins, Tracy
Publisher: Macmillan Publishing Ltd.
Publication Name: Nursing Times
Subject: Health
ISSN: 0954-7762
Year: 2005
Care and treatment, Diagnosis, Personality disorders

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United Kingdom
Similar abstracts:
  • Abstracts: A dry run. A guide to selecting and using urinary sheaths. Timely intervention
  • Abstracts: Antidepressant use in psychiatry and medicine: importance for dental practice. Age Effects on Antidepressant-Induced ManicConversion
  • Abstracts: Using an interactive video disk in breast cancer patient support. Meeting the needs of younger women with breast cancer
  • Abstracts: Levonorgestrel. Ringing the changes in primary care
  • Abstracts: Levonorgestrel. Subarachnoid hemorrhage
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.